EX-23.1 10 nvls-20161231ex2314bfc3a.htm EX-23.1 nvls_Ex_23-1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

1.

Registration Statement (Form S-8 No. 333-205220) pertaining to the 2012 Stock Incentive Plan, 2015 Equity Incentive Plan, and Employee Stock Purchase Plan of Nivalis Therapeutics, Inc.,

2.

Registration Statement (Form S-8 No. 333-211197) pertaining to the Employment Inducement Awards, granted by Nivalis Therapeutics, Inc., and

 

3.

Registration Statement (Form S-3 No. 333-212404)  of  Nivalis Therapeutics, Inc.

 

of our report dated February 13, 2017, with respect to the financial statements of Nivalis Therapeutics, Inc., included in this Annual Report (Form 10-K) of Nivalis Therapeutics, Inc. for the year ended December 31, 2016.

/s/ Ernst & Young, LLP

Denver, Colorado

February 13, 2017